150 related articles for article (PubMed ID: 20469997)
1. Closing in on the pathogenesis of the 5q- syndrome.
Post SM; Quintás-Cardama A
Expert Rev Anticancer Ther; 2010 May; 10(5):655-8. PubMed ID: 20469997
[TBL] [Abstract][Full Text] [Related]
2. Myelodysplastic syndrome with del (5q) and JAK2(V617F) mutation transformed to acute myeloid leukaemia with complex karyotype.
Pich A; Godio L; Riera L; Cavaliere C; Kerim S; Bonello L; Francia di Celle P
Ann Hematol; 2016 Feb; 95(3):525-7. PubMed ID: 26750119
[No Abstract] [Full Text] [Related]
3. Recurrent genetic defects on chromosome 5q in myeloid neoplasms.
Hosono N; Makishima H; Mahfouz R; Przychodzen B; Yoshida K; Jerez A; LaFramboise T; Polprasert C; Clemente MJ; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Sanada M; Cui E; Verma AK; McDevitt MA; List AF; Saunthararajah Y; Sekeres MA; Boultwood J; Ogawa S; Maciejewski JP
Oncotarget; 2017 Jan; 8(4):6483-6495. PubMed ID: 28031539
[TBL] [Abstract][Full Text] [Related]
4. Molecular dissection of the 5q deletion in myelodysplastic syndrome.
Ebert BL
Semin Oncol; 2011 Oct; 38(5):621-6. PubMed ID: 21943668
[TBL] [Abstract][Full Text] [Related]
5. Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
Fernandez-Mercado M; Burns A; Pellagatti A; Giagounidis A; Germing U; Agirre X; Prosper F; Aul C; Killick S; Wainscoat JS; Schuh A; Boultwood J
Haematologica; 2013 Dec; 98(12):1856-64. PubMed ID: 23831921
[TBL] [Abstract][Full Text] [Related]
6. Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome.
Kumar MS; Narla A; Nonami A; Mullally A; Dimitrova N; Ball B; McAuley JR; Poveromo L; Kutok JL; Galili N; Raza A; Attar E; Gilliland DG; Jacks T; Ebert BL
Blood; 2011 Oct; 118(17):4666-73. PubMed ID: 21873545
[TBL] [Abstract][Full Text] [Related]
7. 5q- syndrome.
Boultwood J; Pellagatti A; Wainscoat JS
Curr Pharm Des; 2012; 18(22):3180-3. PubMed ID: 22571696
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of microRNAs in CD34+ cells of 5q- syndrome.
Votavova H; Grmanova M; Dostalova Merkerova M; Belickova M; Vasikova A; Neuwirtova R; Cermak J
J Hematol Oncol; 2011 Jan; 4():1. PubMed ID: 21211043
[TBL] [Abstract][Full Text] [Related]
9. TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis.
Kulasekararaj AG; Smith AE; Mian SA; Mohamedali AM; Krishnamurthy P; Lea NC; Gäken J; Pennaneach C; Ireland R; Czepulkowski B; Pomplun S; Marsh JC; Mufti GJ
Br J Haematol; 2013 Mar; 160(5):660-72. PubMed ID: 23297687
[TBL] [Abstract][Full Text] [Related]
10. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome.
Barlow JL; Drynan LF; Hewett DR; Holmes LR; Lorenzo-Abalde S; Lane AL; Jolin HE; Pannell R; Middleton AJ; Wong SH; Warren AJ; Wainscoat JS; Boultwood J; McKenzie AN
Nat Med; 2010 Jan; 16(1):59-66. PubMed ID: 19966810
[TBL] [Abstract][Full Text] [Related]
11. A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG).
Jaju RJ; Haas OA; Neat M; Harbott J; Saha V; Boultwood J; Brown JM; Pirc-Danoewinata H; Krings BW; Müller U; Morris SW; Wainscoat JS; Kearney L
Blood; 1999 Jul; 94(2):773-80. PubMed ID: 10397745
[TBL] [Abstract][Full Text] [Related]
12. Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q.
Panagiota V; Meggendorfer M; Kubasch AS; Gabdoulline R; Krönke J; Mies A; Shahswar R; Kandziora C; Klement P; Schiller J; Göhring G; Haferlach C; Ganster C; Shirneshan K; Gutermuth A; Thiede C; Germing U; Schroeder T; Kobbe G; Klesse S; Koenecke C; Schlegelberger B; Kröger N; Haase D; Döhner K; Sperr WR; Valent P; Ganser A; Thol F; Haferlach T; Platzbecker U; Heuser M
Am J Hematol; 2021 Jun; 96(6):E207-E210. PubMed ID: 33725366
[No Abstract] [Full Text] [Related]
13. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.
Starczynowski DT; Kuchenbauer F; Argiropoulos B; Sung S; Morin R; Muranyi A; Hirst M; Hogge D; Marra M; Wells RA; Buckstein R; Lam W; Humphries RK; Karsan A
Nat Med; 2010 Jan; 16(1):49-58. PubMed ID: 19898489
[TBL] [Abstract][Full Text] [Related]
14. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
[TBL] [Abstract][Full Text] [Related]
15. The 5q- syndrome: biology and treatment.
Padron E; Komrokji R; List AF
Curr Treat Options Oncol; 2011 Dec; 12(4):354-68. PubMed ID: 21964863
[TBL] [Abstract][Full Text] [Related]
16. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
[TBL] [Abstract][Full Text] [Related]
17. Deletion 5q MDS: molecular and therapeutic implications.
Komrokji RS; Padron E; Ebert BL; List AF
Best Pract Res Clin Haematol; 2013 Dec; 26(4):365-75. PubMed ID: 24507813
[TBL] [Abstract][Full Text] [Related]
18. High level of full-length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide.
Jonasova A; Bokorova R; Polak J; Vostry M; Kostecka A; Hajkova H; Neuwirtova R; Siskova M; Sponerova D; Cermak J; Mikulenkova D; Cervinek L; Brezinova J; Michalova K; Fuchs O
Eur J Haematol; 2015 Jul; 95(1):27-34. PubMed ID: 25284710
[TBL] [Abstract][Full Text] [Related]
19. Genetic deletions in AML and MDS.
Ebert BL
Best Pract Res Clin Haematol; 2010 Dec; 23(4):457-61. PubMed ID: 21130407
[TBL] [Abstract][Full Text] [Related]
20. [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: I. pathogenesis and pathophysiology of bone-marrow failure; 3. Myelodysplastic syndrome].
Mitani K
Nihon Naika Gakkai Zasshi; 2012 Jul; 101(7):1898-905. PubMed ID: 22896992
[No Abstract] [Full Text] [Related]
[Next] [New Search]
